Abstract
Present research efforts are focused in developing compression-coated ketorolac tromethamine tablets to improve the drug levels in colon by retarding the drug release in the stomach and small intestine. To achieve this objective, core tablets containing ketorolac tromethamine were prepared by direct compression and compression coated with sodium alginate. The developed tablets were evaluated for physical properties, in vitro drug release, X-ray imaging, and pharmacokinetic studies in human volunteers. Based on the in vitro drug release study, the optimized formulation showed very little drug release (6.75 ± 0.49 %) in the initial lag period of 5 h, followed by progressive release up to 97.47 ± 0.93 % within 24 h. The X-ray imaging of tablets in human volunteers showed that the tablets reached the colon without disintegrating in the upper gastrointestinal tract. From the pharmacokinetic study, the C max of colon-targeted tablets was 3,486.70 ng/ml at T max 10 h, whereas in the case of immediate-release tablets, the C max of 4,506.31 ng/ml at T max 2 h signifies the ability of compression-coated tablets to target the colon. In conclusion, compression-coated tablets are suitable to deliver ketorolac tromethamine to the colon.
Similar content being viewed by others
References
Vincent HL, Suman KM. Drug delivery-oral colon-specific. In: Swarbick J, Boylan CJ, editors. Encyclopedia of pharmaceutical technology. New York: Marcel Dekker; 2002. p. 871–85.
Krishnaiah YSR, Satyanarayana S, Ramaprasad YV, Narasimharao S. Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm. 1998;171:137–46.
Maroni A, Zema L, Curto MDD, Foppoli A, Gazzaniga A. Oral colon delivery of insulin with the aid of functional adjuvants. Adv Drug Deliv Rev. 2012;64:540–56.
Vemula SK, Veerareddy PR. Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Technol. 2009;1(1):1–35.
Asghar LF, Chandran S. Multiparticulate formulation approach to colon-specific drug delivery: current perspectives. J Pharm Sci. 2006;9(3):327–38.
Kumar M, Ali A, Kaldhone P, Shirode A, Kadam VJ. Platform technologies for colon targeted drug delivery system. J Pharm Res. 2010;3(3):543–7.
Aurora J, Talwar N, Pathak V, Colonic drug delivery challenges and opportunities—an overview. Eur Gastro Rev. 2006;1–6.
Cheng G, Feng A, Zou M. Time and pH dependent colon specific drug delivery for orally administered diclofencac sodium and 5-amino salicylic acid. World J Gastroenterol. 2004;10(12):1769–74.
Sinha VR, Bhinje JR, Kumaria R, Kumar M. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Deliv. 2006;13:221–5.
Wu B, Shun N, Wei X, Wu W. Characterization of 5-fluorouracil release from hydroxypropyl methylcellulose compression-coated tablets. Pharm Dev Technol. 2007;12:203–10.
Veerareddy PR, Vemula SK. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurboprofen. J Drug Target. 2012;20(8):703–14.
Chickpetty SM, Baswaraj R, Nanjwade BK. Studies on development of novel combined time and pH dependent solventless compression coated delivery systems for colonic delivery of diclofenac sodium. Asian J Pharm Clin Res. 2010;3(2):110–3.
Maroni A, Curto MDD, Serratoni M, Zema L, Foppoli A, Gazzaniga A, et al. Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release. Eur J Pharm Biopharm. 2009;72:246–51.
Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm. 2012;427:153–62.
Makhlof A, Tozuka Y, Takeuchi H. pH-sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur J Pharm Biopharm. 2009;72:1–8.
Asghar LF, Chure CB, Chandran S. Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum compression coated bases. AAPS Pharm Sci Technol. 2009;10(2):418–29.
Hashem FM, Shaker DS, Nasr M, Saad IE, Ragaey R. Guar gum and hydroxy propyl methylcellulose compressed coated tablets for colonic drug delivery: in vitro and in vivo evaluation in healthy human volunteers. Drug Discov Ther. 2011;5:90–5.
Mandal S, Basu SK, Sa B. Ca2+ ion cross-linked interpenetrating network matrix tablets of polyacrylamide-grafted-sodium alginate and sodium alginate for sustained release of diltiazem hydrochloride. Carbohydr Polym. 2010;82:867–73.
Brahmankar DM, Karwa RM, Jaiswal SB. Cellulose matrix for controlled release of keterolac tromethamine. India Drugs. 1996;33(3):120–3.
Chopra D, Sinha VR, Singh M. Thermal and isothermal methods in development of sustained release dosage forms of ketorolac tromethamine. Eur J Chem. 2008;5(2):316–22.
El-Kamel AH, Abdel-Aziz AM, Fatani AJ, El-Subbagh HI. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. Int J Pharm. 2008;358:248–55.
Vemula SK, Veerareddy PR. Formulation, evaluation and pharmacokinetics of ketorolac tromethamine time-dependent colon targeted drug delivery system. Exp Opin Drug Deliv. 2013;10(1):33–45.
Wu B, Shun N, Wei X, Lu Y, Wu W. Biphasic release of indomethacin from HPMC/pectin/calcium compression coated tablet: I. Characterization and mechanistic study. Eur J Pharm Biopharm. 2007;67:707–14.
Valluru R, Siddaramaiah T, Pramod M. Influence of natural polymer coating on novel colon targeting drug delivery system. J Mater Sci. 2008;19:2131–6.
Talukder RM, Fassihi R. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system. J Pharm Pharmacol. 2008;60:1297–303.
Chaudhary A, Tiwari N, Jain V, Singh R. Microporous bilayer osmotic tablet for colon-specific delivery. Eur J Pharm Biopharm. 2011;78:134–40.
Mathews BR. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm. 1999;25:831–56.
Tugcu-Demiroz F, Acarturk F, Takka S, Konus-Boyunaga O. In vitro and in vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery. J Drug Target. 2004;12:105–12.
Vemula SK, Veerareddy PR. Formulation and evaluation of ketorolac tromethamine tablets for time and pH dependent colon specific delivery. J Curr Pharm Res. 2011;8(1):31–9.
Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J Control Release. 2003;26:213–20.
Ghimire M, Hodges LA, Band J, Lindsay B, Mahony BO, McInnes FJ, et al. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. Eur J Pharm Biopharm. 2011;77:148–57.
Grahnen A. Design of bioavailability studies. Pharm Int. 1984;5:100–3.
Krishnaiah YSR, Raju VP, Kumar DB, Satyanarayana V, Karthikeyan RS, Bhaskar P. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of mebendazole in healthy volunteers. J Control Release. 2003;88:95–103.
Krishnaiah YSR, Satyanarayana S, Dinesh Kumar B, Karthikeyan RS, Bhaskar P. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci. 2003;19:355–62.
Vyas SP, Roop KK. Controlled drug delivery concepts and advances. Delhi: Vallabh Prakashan Publishers; 1999. p. 218–56.
Acknowledgments
The authors acknowledge Bright Labs, Hyderabad, India and Matrix Laboratories, Hyderabad, India for the gift sample of ketorolac tromethamine and sodium alginate. The authors also thank the Principal and Management, Jangaon Institute of Pharmaceutical Sciences for providing facilities.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vemula, S.K., Veerareddy, P.R. & Devadasu, V.R. Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery. Drug Deliv. and Transl. Res. 4, 310–319 (2014). https://doi.org/10.1007/s13346-014-0195-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-014-0195-x